TD Cowen Upgrades Moderna (MRNA) to Outperform, 'The Risk/Reward And The Catalyst Path Ahead Is Favorable'

Go back to TD Cowen Upgrades Moderna (MRNA) to Outperform, 'The Risk/Reward And The Catalyst Path Ahead Is Favorable'
Marina Biotech, Inc. (NASDAQ: MRNA) Delayed: 221.72 -1.04 (0.47%)
Previous Close $222.76    52 Week High $0.52 
Open $220.53    52 Week Low $0.08 
Day High $227.81    P/E N/A 
Day Low $217.22    EPS $-3.80 
Volume 9,025,870